236 related articles for article (PubMed ID: 21454562)
21. Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
Dong M; Li Z; Zang M; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2003 Nov; 278(48):48300-12. PubMed ID: 14500709
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
Harikumar KG; Lam PC; Dong M; Sexton PM; Abagyan R; Miller LJ
J Biol Chem; 2007 Nov; 282(45):32834-43. PubMed ID: 17827151
[TBL] [Abstract][Full Text] [Related]
23. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.
Dong M; Pinon DI; Miller LJ
Regul Pept; 2002 Nov; 109(1-3):181-7. PubMed ID: 12409231
[TBL] [Abstract][Full Text] [Related]
24. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.
Dong M; Wang Y; Hadac EM; Pinon DI; Holicky E; Miller LJ
J Biol Chem; 1999 Jul; 274(27):19161-7. PubMed ID: 10383421
[TBL] [Abstract][Full Text] [Related]
25. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
Dong M; Lam PC; Orry A; Sexton PM; Christopoulos A; Abagyan R; Miller LJ
J Biol Chem; 2016 Mar; 291(10):5172-84. PubMed ID: 26740626
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for ligand recognition of incretin receptors.
Underwood CR; Parthier C; Reedtz-Runge S
Vitam Horm; 2010; 84():251-78. PubMed ID: 21094903
[TBL] [Abstract][Full Text] [Related]
27. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
Dong M; Lam PC; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2008 Aug; 74(2):413-22. PubMed ID: 18467541
[TBL] [Abstract][Full Text] [Related]
28. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
Dong M; Pinon DI; Asmann YW; Miller LJ
Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
[TBL] [Abstract][Full Text] [Related]
29. Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.
Zang M; Dong M; Pinon DI; Ding XQ; Hadac EM; Li Z; Lybrand TP; Miller LJ
Mol Pharmacol; 2003 May; 63(5):993-1001. PubMed ID: 12695527
[TBL] [Abstract][Full Text] [Related]
30. Molecular evolution of GPCRs: GLP1/GLP1 receptors.
Hwang JI; Yun S; Moon MJ; Park CR; Seong JY
J Mol Endocrinol; 2014 Jun; 52(3):T15-27. PubMed ID: 24598200
[TBL] [Abstract][Full Text] [Related]
31. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
32. Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor.
Dong M; Pinon DI; Cox RF; Miller LJ
J Biol Chem; 2004 Jul; 279(30):31177-82. PubMed ID: 15155765
[TBL] [Abstract][Full Text] [Related]
33. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
34. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
Ding XQ; Dolu V; Hadac EM; Holicky EL; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2001 Feb; 276(6):4236-44. PubMed ID: 11050076
[TBL] [Abstract][Full Text] [Related]
35. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
Wilmen A; Göke B; Göke R
FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
[TBL] [Abstract][Full Text] [Related]
36. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.
Dong M; Xu X; Ball AM; Makhoul JA; Lam PC; Pinon DI; Orry A; Sexton PM; Abagyan R; Miller LJ
FASEB J; 2012 Dec; 26(12):5092-105. PubMed ID: 22964305
[TBL] [Abstract][Full Text] [Related]
37. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
38. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.
Dong M; Zang M; Pinon DI; Li Z; Lybrand TP; Miller LJ
Mol Endocrinol; 2002 Nov; 16(11):2490-501. PubMed ID: 12403838
[TBL] [Abstract][Full Text] [Related]
39. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
[TBL] [Abstract][Full Text] [Related]
40. Insights into the impact of phenolic residue incorporation at each position along secretin for receptor binding and biological activity.
Dong M; Pinon DI; Miller LJ
Regul Pept; 2013 Jan; 180():5-11. PubMed ID: 23142313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
